Interaction of Quercus infectoria Gall's Extract and Vancomycin Against Staphylococcus aureus with Reduce Susceptibility to Vancomycin

被引:0
|
作者
Jaffar, Norzawani [1 ]
Basri, Dayang Fredalina [1 ]
Zin, Noraziah M. [1 ]
机构
[1] Univ Kebangsaan Malaysia, Fak Sains Kesihatan Bersekutu, Kuala Lumpur 50300, Malaysia
来源
SAINS MALAYSIANA | 2011年 / 40卷 / 11期
关键词
Anti-MRSA; Quercus infectoria gall; vancomycin; METHICILLIN-RESISTANT; GROWTH;
D O I
暂无
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Methicillin-resistant Staphylococcus aureus (MRSA) is a versatile pathogen widespread, and tend to be multi-resistant towards almost all of currently available antibiotics. The gall of Quercus infectoria or locally known as manjakani in Malaysia was known to have antibacterial activity. The aim of this study was to evaluate the interaction effect of Q. infectoria gall extract with vancomycin against five MRSA strains and two Vancomycin Intermediate Staphylococcus aureus (VISA) strains. The extracts were prepared using acetone, methanol and aqueous. The microbroth serial dilution technique was employed using 96-well microtiter plate for determination of MIC values. The effect of interaction between Q. infectoria gall extract and vancomycin was evaluated using the checkerboard method to obtain the Fractional inhibitory concentration (FIC) index value. The extracts combination with vancomycin displayed synergism for acetone extract against MRSA ATCC 43300 (0.3124), Sa7 (0.3750) and VISA U9495 (0.3750), while aqueous extract were synergistic against MRSA Sa7 (0.4167) and VISA U9495 (0.3958) and N316 (0.5000). On the other hand, vancomycin combination with methanol only exhibited synergistic effect towards ATCC 49476 (0.3750) but additive against 6 other strains tested. This interaction effect showed their potential and importance in development or modification of drugs against MRSA.
引用
收藏
页码:1237 / 1241
页数:5
相关论文
共 50 条
  • [31] Determination of the post-antibiotic effect (PAE) of combinations of extracts from galls of Quercus infectoria with vancomycin against methicillin-resistant Staphylococcus aureus (MRSA)
    Amman, Vithya
    Basri, Dayang Fredalina
    Huyop, Fahrul
    AFRICAN JOURNAL OF BIOTECHNOLOGY, 2011, 10 (79): : 18274 - 18278
  • [32] Evaluation of telavancin susceptibility in isolates of Staphylococcus aureus with reduced susceptibility to vancomycin
    McMullen, Allison R.
    Lainhart, William
    Wallace, Meghan A.
    Shupe, Angela
    Burnham, Carey-Ann D.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2019, 38 (12) : 2323 - 2330
  • [33] Evaluation of telavancin susceptibility in isolates of Staphylococcus aureus with reduced susceptibility to vancomycin
    Allison R. McMullen
    William Lainhart
    Meghan A. Wallace
    Angela Shupe
    Carey-Ann D. Burnham
    European Journal of Clinical Microbiology & Infectious Diseases, 2019, 38 : 2323 - 2330
  • [34] Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid
    Barber, Katie E.
    Smith, Jordan R.
    Raut, Animesh
    Rybak, Michael J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (01) : 152 - 155
  • [35] Synergistic interaction of vancomycin (VAN) plus Oxacillin (OXA) against hetero-vancomycin-resistant Staphylococcus aureus (hVRSA)
    Kim, YS
    Jung, SI
    Oh, WS
    Cho, HL
    Peck, KR
    Lee, NY
    Kim, SM
    Song, JH
    CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) : 231 - 231
  • [36] In vitro synergistic effects of various combinations of vancomycin and non-beta-lactams against Staphylococcus aureus with reduced susceptibility to vancomycin
    Kang, Yu Ri
    Chung, Doo Ryeon
    Kim, Jungok
    Baek, Jin Yang
    Kim, So Hyun
    Ha, Young Eun
    Kang, Cheol-In
    Peck, Kyong Ran
    Song, Jae-Hoon
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2016, 86 (03) : 293 - 299
  • [37] Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus
    Cui, LZ
    Tominaga, E
    Neoh, HM
    Hiramatsu, K
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (03) : 1079 - 1082
  • [38] Susceptibility of vancomycin resistant enterococci, methicillin resistant Staphylococcus aureus and vancomycin intermediate staphylococci to linezolid
    Garganera, DAC
    Carey, R
    O'Keefe, JP
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1179 - 1179
  • [39] Impact of rpoB Mutations on Reduced Vancomycin Susceptibility in Staphylococcus aureus
    Watanabe, Yukiko
    Cui, Longzhu
    Katayama, Yuki
    Kozue, Kishii
    Hiramatsu, Keiichi
    JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (07) : 2680 - 2684
  • [40] The first Staphylococcus aureus isolates with reduced susceptibility to vancomycin in Poland
    Krzyszton-Russjan, J
    Gniadkowski, M
    Polowniak-Pracka, H
    Hagmajer, E
    Hryniewicz, W
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (06) : 1065 - 1069